Molina Healthcare, Inc. (MOH)
NYSE: MOH · Real-Time Price · USD
148.62
+4.66 (3.24%)
Mar 18, 2026, 3:58 PM EDT - Market open
Molina Healthcare Stock Forecast
Stock Price Forecast
The 13 analysts that cover Molina Healthcare stock have a consensus rating of "Hold" and an average price target of $157.15, which forecasts a 5.74% increase in the stock price over the next year. The lowest target is $124 and the highest is $220.
Price Target: $157.15 (+5.74%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Molina Healthcare stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 3 | 3 | 3 | 3 | 2 | 2 |
| Hold | 9 | 9 | 9 | 9 | 10 | 11 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 13 | 13 | 13 | 13 | 13 | 14 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Hold Maintains $145 → $151 | Hold | Maintains | $145 → $151 | +1.60% | Mar 12, 2026 |
| Mizuho | Mizuho | Buy Maintains $220 → $180 | Buy | Maintains | $220 → $180 | +21.11% | Mar 12, 2026 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $158 → $128 | Hold | Maintains | $158 → $128 | -13.87% | Mar 4, 2026 |
| Wells Fargo | Wells Fargo | Buy → Hold Downgrades $208 → $141 | Buy → Hold | Downgrades | $208 → $141 | -5.13% | Feb 20, 2026 |
| Truist Securities | Truist Securities | Hold Maintains $190 → $145 | Hold | Maintains | $190 → $145 | -2.44% | Feb 17, 2026 |
Financial Forecast
Revenue This Year
45.13B
from 43.56B
Increased by 3.59%
Revenue Next Year
47.97B
from 45.13B
Increased by 6.30%
EPS This Year
7.78
from 8.92
Decreased by -12.82%
EPS Next Year
10.99
from 7.78
Increased by 41.31%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 48.7B | 53.8B | |||
| Avg | 45.1B | 48.0B | |||
| Low | 42.8B | 42.7B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 11.8% | 19.2% | |||
| Avg | 3.6% | 6.3% | |||
| Low | -1.7% | -5.3% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 14.70 | 17.85 | |||
| Avg | 7.78 | 10.99 | |||
| Low | 4.90 | 5.91 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 64.8% | 129.5% | |||
| Avg | -12.8% | 41.3% | |||
| Low | -45.1% | -24.0% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.